ZetrOZ initiates trial for LITUS in knee osteoarthritis pain relief
ZetrOZ, Inc. is conducting a trial to evaluate the efficacy of long-duration low intensity therapeutic ultrasound for knee osteoarthritis pain relief.
Asset / Drug
Drug and asset intelligence for LITUS with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.